H. Lundbeck A/S (HLBBF)
6.76
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
H. Lundbeck Price to Book Value : 1.632 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.632 |
| October 08, 2026 | 1.632 |
| October 07, 2026 | 1.632 |
| October 06, 2026 | 1.632 |
| October 05, 2026 | 1.632 |
| October 02, 2026 | 1.632 |
| October 01, 2026 | 1.632 |
| September 30, 2026 | 1.632 |
| September 29, 2026 | 1.632 |
| September 28, 2026 | 1.631 |
| September 25, 2026 | 1.631 |
| September 24, 2026 | 1.631 |
| September 23, 2026 | 1.631 |
| September 22, 2026 | 1.631 |
| September 21, 2026 | 1.631 |
| September 18, 2026 | 1.631 |
| September 17, 2026 | 1.631 |
| September 16, 2026 | 1.631 |
| September 15, 2026 | 1.631 |
| September 14, 2026 | 1.631 |
| September 11, 2026 | 1.680 |
| September 10, 2026 | 1.680 |
| September 09, 2026 | 1.680 |
| September 08, 2026 | 1.680 |
| September 04, 2026 | 1.680 |
| Date | Value |
|---|---|
| September 03, 2026 | 1.680 |
| September 02, 2026 | 1.680 |
| September 01, 2026 | 1.680 |
| August 31, 2026 | 1.680 |
| August 28, 2026 | 1.680 |
| August 27, 2026 | 1.680 |
| August 26, 2026 | 1.603 |
| August 25, 2026 | 1.603 |
| August 24, 2026 | 1.603 |
| August 21, 2026 | 1.603 |
| August 20, 2026 | 1.603 |
| August 19, 2026 | 1.603 |
| August 18, 2026 | 1.603 |
| August 17, 2026 | 1.603 |
| August 14, 2026 | 1.603 |
| August 13, 2026 | 1.461 |
| August 12, 2026 | 1.461 |
| August 11, 2026 | 1.461 |
| August 10, 2026 | 1.553 |
| August 07, 2026 | 1.553 |
| August 06, 2026 | 1.553 |
| August 05, 2026 | 1.553 |
| August 04, 2026 | 1.678 |
| August 03, 2026 | 1.678 |
| July 31, 2026 | 1.678 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Novo Nordisk A/S | 5.047 |
| ALK-Abello A/S | 7.042 |
| Xeris Biopharma Holdings, Inc. | -- |
| AstraZeneca PLC | 10.43 |
| ANI Pharmaceuticals, Inc. | 2.842 |
Price to Book Value Related Metrics
| PE Ratio | 11.06 |
| PS Ratio | 1.674 |
| PEG Ratio | 0.5206 |
| Price to Free Cash Flow | 9.313 |
| Price | 6.76 |
| Earnings Yield | 9.04% |
| Market Cap | 6.707B |
| PEGY Ratio | 0.4617 |
| Operating PE Ratio | 6.145 |
| Normalized PE Ratio | 9.334 |